Duane Nash - 05 Jun 2025 Form 4/A - Amendment Insider Report for IMMUNIC, INC. (IMUX)

Role: Executive Chairman, Director
Signature: /s/ Duane Nash
Issuer symbol: IMUX
Transactions as of: 05 Jun 2025
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 20 Jun 2025, 17:15:28 UTC
Date Of Original Report: 09 Jun 2025
Previous filing: 09 Dec 2024
Next filing: 16 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Nash Duane	Executive Chairman, Director	1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK	/s/ Duane Nash	20 Jun 2025	0001591098

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IMUX	Stock Option	Award	$0	+570,000		$0.000000	570,000	05 Jun 2025	Common Stock	570,000	$0.7729	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests in monthly increments over a period of one year from the grant date.

Remarks:

This Form 4/A is being filed to amend the prior Form 4 filed by the Reporting Peron on June 9, 2025 to correct an administrative error that incorrectly reported the number of stock options granted.